Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis.

The aim of the present study was to develop a neuropsychological test battery for patients with juvenile neuronal ceroid lipofuscinosis (JNCL) and to study the development of cognitive functions during the first 5 years after diagnosis. Fourteen patients with JNCL entered the study. Nine patients were homozygous for the major mutation, whereas five were compound heterozygotes. All patients were studied annually with a special neuropsychological test battery (NEPSY) adapted from Luria's neuropsychological test, and modified for the visually handicapped; the Wechsler Intelligence Scale for Children - Revised (WISC-R) was also included. The neurological examinations were scored. Furthermore, 1.OT magnetic resonance imaging scan was performed at the beginning of follow-up and after a mean of 5 years. A decline in verbal IQ (WISC-R) during the follow-up period was found in all subjects except one compound heterozygous male. Short-term memory and digit memory span were already impaired at an early stage of the disease. Orientation to time was found to decline more than orientation to person and place. Motor speed usually became impaired after 10 years of age. Spatial orientation was impaired only in the patients homozygous for the major mutation. The test battery was found to be reliable and easy to use, and offered valuable information on the progress of the disease. It also provided important guidelines for rehabilitation.

[1]  N. Viukari Intolerance to diphenylhydantoin in five cases of Vogt-Spielmeyer disease. , 2008, Journal of mental deficiency research.

[2]  M. Hämäläinen,et al.  Sleep alterations in juvenile neuronal ceroid-lipofuscinosis. , 2000, Pediatric neurology.

[3]  T. Autti,et al.  Clinical and magnetic resonance imaging findings in batten disease: Analysis of the major mutation (1.02‐kb deletion) , 1997, Annals of neurology.

[4]  P. Munroe,et al.  Rapid diagnostic test for the major mutation underlying Batten disease. , 1996, Journal of medical genetics.

[5]  R. Kuzniecky,et al.  Qualitative MRI Segmentation in Mesial Temporal Sclerosis: Clinical Correlations , 1996, Epilepsia.

[6]  P. Munroe,et al.  Prenatal diagnosis of Batten's disease , 1996, The Lancet.

[7]  H. Heiskala,et al.  Brain perfusion SPECT in juvenile neuronal ceroid lipofuscinosis. , 1996, Neuropediatrics.

[8]  R. Kuzniecky Neuroimaging in Pediatric Epilepsy , 1996, Epilepsia.

[9]  A. Shah,et al.  Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses. , 1995, American journal of medical genetics.

[10]  C. Messa,et al.  Spielmeyer-Vogt (Batten, Spielmeyer-Sjögren) disease. Distinctive patterns of cerebral glucose utilization. , 1994, Brain : a journal of neurology.

[11]  L. Peltonen,et al.  Batten disease (Spielmeyer-Vogt disease, juvenile onset neuronal ceroid-lipofuscinosis) gene (CLN3) maps to human chromosome 16. , 1990, Genomics.

[12]  P. Santavuori,et al.  Neuronal ceroid-lipofuscinoses in childhood , 1988, Brain and Development.

[13]  P. Santavuori,et al.  Experience of antioxidant treatment in neuronal ceroid-lipofuscinosis of Spielmeyer-Sjögren type. , 1977, Neuropadiatrie.

[14]  H. Lou,et al.  A Clinical and Psychological Investigation into Juvenile Amaurotic Idiocy in Denmark , 1973, Developmental medicine and child neurology.

[15]  J. Opitz,et al.  Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease. , 1988, American journal of medical genetics. Supplement.

[16]  J. Westlake,et al.  C-band polymorphism: comparison between trisomy 21 cases and mentally retarded controls. , 1980, American journal of medical genetics.